person · Reporting owner
Flanagan James Francis
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CYABRA, INC.CYAB · Entity 8037 | Director | July 10, 2026 | July 13, 2026 |
| Integer Holdings CorpITGR · Entity 4016 | Director | May 20, 2026 | May 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CYABRA, INC.
Report date July 10, 2026 · Filed July 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 224,940 |
Reported balance
After 2026-07-10 transaction · row 1
1 source rowRow 1 · 2026-07-10 · Grant · Acquired 114,940 · Balance 224,940 F1: On July 10, 2026, the Reporting Person purchased 53,650 shares of common stock, par value $0.0001 per share (the "Common Stock"), from the Issuer in a private placement transaction (the "Private Placement") at a purchase price of $0.435 per share. |
| Common Stock Warrants (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.45 | Direct | 114,940 |
Reported balance
After 2026-07-10 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-10 · Purchase · Acquired 114,940 · Balance 114,940 F2: The Reporting Person purchased Series B warrants to purchase up to 53,650 shares of Common Stock (the "Series B Warrants") in the Private Placement. F3: The Series B Warrants will become exercisable upon the receipt of the requisite stockholder approval. F4: The Series B Warrants expire twelve (12) months following the initial exercise date. |
| Common Stock Warrants (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.50 | Direct | 229,880 |
Reported balance
After 2026-07-10 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-07-10 · Purchase · Acquired 114,940 · Balance 229,880 F5: The Reporting Person purchased Series A warrants to purchase up to 53,650 shares of Common Stock (the "Series A Warrants") in the Private Placement. F6: The Series A Warrants will become exercisable upon the receipt of the requisite stockholder approval. F7: The Series A Warrants expire five (5) years following the initial exercise date. |
Filing footnotes · ownership attribution and instrument terms
F1: On July 10, 2026, the Reporting Person purchased 53,650 shares of common stock, par value $0.0001 per share (the "Common Stock"), from the Issuer in a private placement transaction (the "Private Placement") at a purchase price of $0.435 per share.
F2: The Reporting Person purchased Series B warrants to purchase up to 53,650 shares of Common Stock (the "Series B Warrants") in the Private Placement.
F3: The Series B Warrants will become exercisable upon the receipt of the requisite stockholder approval.
F4: The Series B Warrants expire twelve (12) months following the initial exercise date.
F5: The Reporting Person purchased Series A warrants to purchase up to 53,650 shares of Common Stock (the "Series A Warrants") in the Private Placement.
F6: The Series A Warrants will become exercisable upon the receipt of the requisite stockholder approval.
F7: The Series A Warrants expire five (5) years following the initial exercise date.
Integer Holdings Corp
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,377 |
Reported balance
After 2026-05-20 transaction · row 1
1 source rowRow 1 · 2026-05-20 · Grant · Acquired 1,967 · Balance 2,377 F1: Grant of restricted stock units ("RSUs") as of May 20, 2026. RSUs convert into common stock on a one-for-one basis, subject to vesting in approximately equal installments on August 20, 2026, November 20, 2026, February 20, 2027, and May 18, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units ("RSUs") as of May 20, 2026. RSUs convert into common stock on a one-for-one basis, subject to vesting in approximately equal installments on August 20, 2026, November 20, 2026, February 20, 2027, and May 18, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 10, 2026 Filed Jul 13, 2026 21:09 UTC | CYABRA, INC. CYAB · Entity 8037 | PurchaseCommon Stock Warrants (right to buy) · Derivative | 114,940 | $0.50 Strike: $0.50 | $57,470.00 |
DisclosureSEC source: 0001213900-26-077644 · ownership.xml · derivative · entry 3 Flanagan James Francis · CIK 0002055648 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 229,880 Underlying: Common Stock · 114,940 shares Expires not disclosed F5 · security: The Reporting Person purchased Series A warrants to purchase up to 53,650 shares of Common Stock (the "Series A Warrants") in the Private Placement. F6 · derivative.exercise_date: The Series A Warrants will become exercisable upon the receipt of the requisite stockholder approval. F7 · derivative.expiration_date: The Series A Warrants expire five (5) years following the initial exercise date. Read SEC document |
| July 10, 2026 Filed Jul 13, 2026 21:09 UTC | CYABRA, INC. CYAB · Entity 8037 | PurchaseCommon Stock Warrants (right to buy) · Derivative | 114,940 | $0.45 Strike: $0.45 | $51,723.00 |
DisclosureSEC source: 0001213900-26-077644 · ownership.xml · derivative · entry 2 Flanagan James Francis · CIK 0002055648 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,940 Underlying: Common Stock · 114,940 shares Expires not disclosed F2 · security: The Reporting Person purchased Series B warrants to purchase up to 53,650 shares of Common Stock (the "Series B Warrants") in the Private Placement. F3 · derivative.exercise_date: The Series B Warrants will become exercisable upon the receipt of the requisite stockholder approval. F4 · derivative.expiration_date: The Series B Warrants expire twelve (12) months following the initial exercise date. Read SEC document |
| July 10, 2026 Filed Jul 13, 2026 21:09 UTC | CYABRA, INC. CYAB · Entity 8037 | GrantCommon Stock | 114,940 | $0.44 | $49,998.90 |
DisclosureSEC source: 0001213900-26-077644 · ownership.xml · nonDerivative · entry 1 Flanagan James Francis · CIK 0002055648 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,940 F1 · shares: On July 10, 2026, the Reporting Person purchased 53,650 shares of common stock, par value $0.0001 per share (the "Common Stock"), from the Issuer in a private placement transaction (the "Private Placement") at a purchase price of $0.435 per share. Read SEC document |
| May 20, 2026 Filed May 22, 2026 20:52 UTC | Integer Holdings Corp ITGR · Entity 4016 | GrantCommon Stock | 1,967 | $0.00 | $0.00 |
DisclosureSEC source: 0002055648-26-000010 · wk-form4_1779483131.xml · nonDerivative · entry 1 Flanagan James Francis · CIK 0002055648 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,377 F1 · shares: Grant of restricted stock units ("RSUs") as of May 20, 2026. RSUs convert into common stock on a one-for-one basis, subject to vesting in approximately equal installments on August 20, 2026, November 20, 2026, February 20, 2027, and May 18, 2027. Read SEC document |
| May 14, 2026 Filed May 18, 2026 20:01 UTC | CYABRA, INC. CYAB · Entity 8037 | GrantCommon Stock | 110,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-058422 · ownership.xml · nonDerivative · entry 1 Flanagan James Francis · CIK 0002055648 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,000 F1 · shares: On May 14, 2026, the Reporting Person was granted 110,000 restricted stock units ("RSUs") of the Issuer pursuant to the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan, vesting over three years through April 1, 2029. Each RSU represents the right to receive one share of common stock, par value $0.0001 per share. Read SEC document |
| March 12, 2026 Filed Mar 26, 2026 01:38 UTC | Integer Holdings Corp ITGR · Entity 4016 | GrantCommon Stock | 410 | $0.00 | $0.00 |
DisclosureSEC source: 0002055648-26-000008 · wk-form4_1774489120.xml · nonDerivative · entry 1 Flanagan James Francis · CIK 0002055648 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 410 F1 · shares: Grant of restricted stock units ("RSUs") as of March 12, 2026. RSUs convert into common stock on a one-for-one basis, subject to vesting on May 19, 2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.